Agency Information Collection Activities: Proposed Collection; Comment Request; Withdrawal, 48182-48183 [2024-12355]
Download as PDF
<![CDATA[
48182
Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices
20892, (301) 594–7735, pandharej2@
csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Hepatobiliary Pathophysiology Study
Section.
Date: June 27–28, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852 (In
Person).
Contact Person: Jianxin Hu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2156,
Bethesda, MD 20892, 301–827–4417,
jianxinh@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Cellular and Molecular Immunology—B
Study Section.
Date: June 27–28, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liying Guo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, (301) 827–
7728, lguo@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 30, 2024.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12263 Filed 6–4–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications or
contract proposals discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
VerDate Sep<11>2014
16:50 Jun 04, 2024
Jkt 262001
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
K99/R00 MOSAIC-Maximizing Opportunities
for Scientific and Academic Independent
Careers.
Date: July 8, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Rockledge I 6705 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Y, Bethesda, MD 20892, (301) 827–7911,
nawazish.naqvi@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Multi-Ethnic Study in Atherosclerosis
(MESA).
Date: July 11, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific
Review Officer, Office of Scientific Review/
DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208–S Bethesda, MD
20892, (301) 435–0270 sun.saret@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Short Term Training Program.
Date: July 15, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Michael P. Reilly, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–Z
Bethesda, MD 20892, (301) 827–7975
reillymp@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Physician Scientist Transition to
Independence in Blood Science Research
(R00—Clinical Trial Optional).
Date: July 17, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Y Bethesda, MD 20892, (301) 827–7911
nawazish.naqvi@nih.gov.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Catalyze Product Definition for Small
Molecules and Biologics.
Date: July 18, 2024.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Rajiv Kumar, Ph.D.,
Branch Chief, Blood and Vascular Branch
Office of Scientific Review/DERA, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6705 Rockledge Drive,
208–W Bethesda, MD 20892, 301–827–4612
rajiv.kumar@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
R35 OIA Review.
Date: July 24–25, 2024.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814 (Hybrid
Meeting).
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 209–B Bethesda,
MD 20892, (301) 827–7953 kristen.page@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–12265 Filed 6–4–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Withdrawal
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
E:\FR\FM\05JNN1.SGM
05JNN1
48183
Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices
Reports Clearance Officer at (240) 276–
1243.
Comments are invited on: (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Project: Minority AIDS InitiativeManagement Reporting Tools (MAI–
MRTs)—(OMB No. 0930–0357)—
Renewal
Withdrawal: The document published
to the Federal Register on 5/29/2025
under FR Doc 2024–11739 is being
withdrawn due to error in submission
causing comment timeframe to be longer
than required. The document should
have requested to be published for 30days instead of 60-days. A new notice
will be published with the correct
timeframe included.
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is requesting from
the Office of Management and Budget
(OMB) approval for the renewal of
Minority AIDS Initiative (MAI)
monitoring tools, which includes both
youth and adult questionnaires, as well
as the quarterly progress report. This
revision includes the inclusion of new
cohorts, substantial revisions to the
youth and adult questionnaires, updates
to the data used to estimate response
rates and expected numbers of
participants by service duration (see
table 1 below).
The cohorts of grantees funded by the
MAI and included in this clearance
request are:
• Prevention Navigators 2019
• Prevention Navigators 2020
• Prevention Navigators 2021
• Prevention Navigators 2022
• Prevention Navigators 2023
The target population for the grantees
will be at-risk minority adolescents and
young adults. All MAI grantees are
expected to report their monitoring data
using SAMHSA’s Strategic Prevention
Framework (SPF) and to target minority
populations, as well as other high-risk
groups residing in communities of color
with high prevalence of Substance
Abuse and HIV/AIDS. The primary
objectives of the monitoring tools
include:
• Assess the success of the MAI in
reducing risk factors and increasing
protective factors associated with the
transmission of the Human
Immunodeficiency Virus (HIV),
Hepatitis C Virus (HCV) and other
sexually transmitted diseases (STD).
• Measure the effectiveness of
evidence-based programs and
infrastructure development activities
such as: outreach and training,
mobilization of key stakeholders,
substance abuse and HIV/AIDS
counseling and education, testing,
referrals to appropriate medical
treatment and/or other intervention
strategies (i.e., cultural enrichment
activities, educational and vocational
resources, social marketing campaigns,
and computer-based curricula).
• Investigate intervention types and
features that yield the best outcomes for
specific population groups.
• Assess the extent to which access to
health care was enhanced for
population groups and individuals
vulnerable to behavioral health
disparities residing in communities
targeted by funded interventions.
• Assess the process of adopting and
implementing the SPF with the target
populations.
• Added questions to capture details
on the intervention and the referrals to
the record management section
(completed by grantee staff).
TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN
Number of
respondents
Type of respondent activity
Responses
per
respondent
Total
responses
Total
burden hours
Quarterly Progress Report ...................................................
Adult questionnaire ..............................................................
Youth questionnaire .............................................................
183
10,000
2,500
4
3
3
732
30,000
7,500
4
.20
.20
2,928
6,000
1,500
Total ..............................................................................
12,683
........................
38,232
........................
10,428
Send comments to SAMHSA Reports
Clearance Officer, 5600 Fishers Lane,
Room 15E45, Rockville, Maryland
20857, OR email a copy to samhsapra@
samhsa.hhs.gov. Written comments
should be received by August 5, 2024.
Alicia Broadus,
Public Health Advisor.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
[FR Doc. 2024–12355 Filed 6–4–24; 8:45 am]
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer at (240) 276–1243.
BILLING CODE 4162–20–P
khammond on DSKJM1Z7X2PROD with NOTICES
Hours per
response
VerDate Sep<11>2014
16:50 Jun 04, 2024
Jkt 262001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Project: Minority AIDS InitiativeManagement Reporting Tools (MAI–
MRTs)—(OMB No. 0930–0357)—
Renewal
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Substance Abuse
Prevention (CSAP) is requesting from
the Office of Management and Budget
(OMB) approval for the renewal of the
Minority AIDS Initiative (MAI)
monitoring tools, which includes both
youth and adult questionnaires as well
as the quarterly progress report. This
renewal includes the inclusion of new
cohorts.
The cohorts of grantees funded by the
MAI and included in this clearance
request are:
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 89, Number 109 (Wednesday, June 5, 2024)]
[Notices]
[Pages 48182-48183]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12355]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request; Withdrawal
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA
[[Page 48183]]
Reports Clearance Officer at (240) 276-1243.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Project: Minority AIDS Initiative-Management Reporting Tools (MAI-
MRTs)--(OMB No. 0930-0357)--Renewal
Withdrawal: The document published to the Federal Register on 5/29/
2025 under FR Doc 2024-11739 is being withdrawn due to error in
submission causing comment timeframe to be longer than required. The
document should have requested to be published for 30-days instead of
60-days. A new notice will be published with the correct timeframe
included.
The Substance Abuse and Mental Health Services Administration
(SAMHSA), Center for Substance Abuse Prevention (CSAP) is requesting
from the Office of Management and Budget (OMB) approval for the renewal
of Minority AIDS Initiative (MAI) monitoring tools, which includes both
youth and adult questionnaires, as well as the quarterly progress
report. This revision includes the inclusion of new cohorts,
substantial revisions to the youth and adult questionnaires, updates to
the data used to estimate response rates and expected numbers of
participants by service duration (see table 1 below).
The cohorts of grantees funded by the MAI and included in this
clearance request are:
Prevention Navigators 2019
Prevention Navigators 2020
Prevention Navigators 2021
Prevention Navigators 2022
Prevention Navigators 2023
The target population for the grantees will be at-risk minority
adolescents and young adults. All MAI grantees are expected to report
their monitoring data using SAMHSA's Strategic Prevention Framework
(SPF) and to target minority populations, as well as other high-risk
groups residing in communities of color with high prevalence of
Substance Abuse and HIV/AIDS. The primary objectives of the monitoring
tools include:
Assess the success of the MAI in reducing risk factors and
increasing protective factors associated with the transmission of the
Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV) and other
sexually transmitted diseases (STD).
Measure the effectiveness of evidence-based programs and
infrastructure development activities such as: outreach and training,
mobilization of key stakeholders, substance abuse and HIV/AIDS
counseling and education, testing, referrals to appropriate medical
treatment and/or other intervention strategies (i.e., cultural
enrichment activities, educational and vocational resources, social
marketing campaigns, and computer-based curricula).
Investigate intervention types and features that yield the
best outcomes for specific population groups.
Assess the extent to which access to health care was
enhanced for population groups and individuals vulnerable to behavioral
health disparities residing in communities targeted by funded
interventions.
Assess the process of adopting and implementing the SPF
with the target populations.
Added questions to capture details on the intervention and
the referrals to the record management section (completed by grantee
staff).
Table 1--Estimates of Annualized Hour Burden
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Type of respondent activity respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
Quarterly Progress Report....... 183 4 732 4 2,928
Adult questionnaire............. 10,000 3 30,000 .20 6,000
Youth questionnaire............. 2,500 3 7,500 .20 1,500
-------------------------------------------------------------------------------
Total....................... 12,683 .............. 38,232 .............. 10,428
----------------------------------------------------------------------------------------------------------------
Send comments to SAMHSA Reports Clearance Officer, 5600 Fishers
Lane, Room 15E45, Rockville, Maryland 20857, OR email a copy to
[email protected]. Written comments should be received by August
5, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-12355 Filed 6-4-24; 8:45 am]
BILLING CODE 4162-20-P
